Background: Hypertension, type 2 diabetes mellitus and cardiovascular disease are among the leading causes of mortality globally. Exercise is one of the commonly recommended interventions/preventions for hypertension, type 2 diabetes mellitus and cardiovascular disease. However, the previous reviews have shown conflicting evidence on the effects of exercise. Our objective is to assess the beneficial and harmful effects of adding exercise to usual care for people with hypertension, type 2 diabetes mellitus and/or cardiovascular disease.
Methods: This protocol for a systematic review was undertaken using the recommendations of The Cochrane Collaboration, the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) and the eight-step assessment procedure suggested by Jakobsen et al. We plan to include all relevant randomised clinical trials and cluster-randomised trials assessing the effects of adding exercise to usual care for people with hypertension, type 2 diabetes mellitus and/or cardiovascular disease. We will search the Cochrane Central Register of Controlled Trials (CENTRAL), Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica database (EMBASE), Latin American and Caribbean Health Sciences Literature (LILACS), Science Citation Index Expanded on Web of Science, Chinese Biomedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), Chinese Science Journal Database (VIP) and BIOSIS. We will systematically assess the risks of random errors using Trial Sequential Analysis as well as risks of bias of all included trials. We will create a 'Summary of Findings' table in which we will present our primary and secondary outcomes, and we will assess the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).
Discussion: The present systematic review will have the potential to aid patients, clinicians and decision-makers recommending exercise and thereby, benefit patients with hypertension, type 2 diabetes mellitus and/or cardiovascular disease.
Systematic review registration: PROSPERO CRD42019142313.
Keywords: Cardiovascular disease; Exercise; Hypertension; Meta-analysis; Physical activity; Systematic review; Trial Sequential Analysis; Type 2 diabetes mellitus.
Conflict of interest statement
The authors declare that they have no competing interests.
Ivabradine for coronary artery disease and/or heart failure-a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.Syst Rev. 2019 Feb 1;8(1):39. doi: 10.1186/s13643-019-0957-0. Syst Rev. 2019. PMID: 30709418 Free PMC article.
The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.Syst Rev. 2019 Oct 31;8(1):251. doi: 10.1186/s13643-019-1173-7. Syst Rev. 2019. PMID: 31672170 Free PMC article.
Dexmedetomidine for the management of delirium in critically ill patients-A protocol for a systematic review.Acta Anaesthesiol Scand. 2019 Apr;63(4):549-557. doi: 10.1111/aas.13329. Epub 2019 Jan 31. Acta Anaesthesiol Scand. 2019. PMID: 30701537 Review.
Dexmedetomidine for the prevention of delirium in critically ill patients - A protocol for a systematic review.Acta Anaesthesiol Scand. 2019 Apr;63(4):540-548. doi: 10.1111/aas.13313. Epub 2019 Jan 23. Acta Anaesthesiol Scand. 2019. PMID: 30671925
Nitazoxanide for chronic hepatitis C.Cochrane Database Syst Rev. 2014 Apr 6;(4):CD009182. doi: 10.1002/14651858.CD009182.pub2. Cochrane Database Syst Rev. 2014. PMID: 24706397 Review.
- Olsen Michael H, Angell Sonia Y, Asma Samira, Boutouyrie Pierre, Burger Dylan, Chirinos Julio A, Damasceno Albertino, Delles Christian, Gimenez-Roqueplo Anne-Paule, Hering Dagmara, López-Jaramillo Patricio, Martinez Fernando, Perkovic Vlado, Rietzschel Ernst R, Schillaci Giuseppe, Schutte Aletta E, Scuteri Angelo, Sharman James E, Wachtell Kristian, Wang Ji Guang. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. The Lancet. 2016;388(10060):2665–2712. doi: 10.1016/S0140-6736(16)31134-5. - DOI - PubMed
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041. doi: 10.1097/HJH.0000000000001940. - DOI - PubMed
- WHO. A global brief on hypertension: silent killer, global public health crisis. Geneva, Switzerland: World Health Organization (WHO), 2013 Contract No.: WHO/DCO/WHD/2013.2.